Logo image
Bioisosteric Replacement as a Tool in Anti-HIV Drug Design
Journal article   Open access   Peer reviewed

Bioisosteric Replacement as a Tool in Anti-HIV Drug Design

Alexej Dick and Simon Cocklin
Pharmaceuticals (Basel, Switzerland), v 13(3)
01 Mar 2020
PMID: 32121077
url
https://doi.org/10.3390/ph13030036View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Chemistry, Medicinal Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology
Bioisosteric replacement is a powerful tool for modulating the drug-like properties, toxicity, and chemical space of experimental therapeutics. In this review, we focus on selected cases where bioisosteric replacement and scaffold hopping have been used in the development of new anti-HIV-1 therapeutics. Moreover, we cover field-based, computational methodologies for bioisosteric replacement, using studies from our group as an example. It is our hope that this review will serve to highlight the utility and potential of bioisosteric replacement in the continuing search for new and improved anti-HIV drugs.

Metrics

5 Record Views
39 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Chemistry, Medicinal
Pharmacology & Pharmacy
Logo image